← Leaderboards
Jalpa A. Doshi
University Of Pennsylvania
$3,236,214
Attributed
$3,236,214
Total exposure
4
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $500K · FY2006–22$500K$375K$250K$125K$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
Funding mix
By agency
NIH$1,765,326 · 3
AHRQ$1,470,888 · 1
By mechanism
R01$2,991,929 · 3
R21$244,285 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Pennsylvania
Same institution · by research overlap
- Sean P Hennessy$26,496,214
- Charles Edward Leonard$3,385,825
- Kevin G Volpp$33,636,384
- Karen Glanz$30,942,243
- Robert Gross$16,941,227
Others in their field
Top investigators on “Pharmaceutical Preparations”
- Sonia M Thomas · Research Triangle Institute$701,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- David Heimbrook · Leidos Biomedical Research, Inc.$266,816,120
- Leonard Freedman · Leidos Biomedical Research, Inc.$240,520,687
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$196,976,947
- Lawrence Corey · Fred Hutchinson Cancer Center$196,976,947
Research focus
Pharmaceutical PreparationsSeriesTrendBaseDrug UtilizationCostInsuranceHealth ServicesLinkAcuteGeneric DrugsHealth Care CostsAtypical AntipsychoticHospitalizationAntipsychotic AgentsExpenditureCopaymentBehaviorAdoptedCost ControlCost SharingDesignAdherence (Attribute)Drug Costs
Grant awards (9)
Pharmacy Dispensing Channel and Specialty Drug Adherence and Outcomes among Medicare Beneficiaries$103,773
R21 · FY2022 · AG · contact PI
Pharmacy Dispensing Channel and Specialty Drug Adherence and Outcomes among Medicare Beneficiaries$140,512
R21 · FY2021 · AG · contact PI
Impact of Medicare Part D in Dual Eligibles with Schizophrenia$500,000
R01 · FY2012 · HS · contact PI
Impact of Medicare Part D in Dual Eligibles with Schizophrenia$491,059
R01 · FY2011 · HS · contact PI
Impact of Medicare Part D in Dual Eligibles with Schizophrenia$479,829
R01 · FY2010 · HS · contact PI
Impact of Medicaid Prescription Copayments in Patients with Schizophrenia$287,015
R01 · FY2009 · MH · contact PI
Impact of Medicaid Prescription Copayments in Patients with Schizophrenia$331,971
R01 · FY2008 · MH · contact PI
Impact of Medicaid Prescription Copayments in Patients with Schizophrenia$488,102
R01 · FY2007 · MH · contact PI
Life Cycle Effects of Health Insurance on Elderly Health$413,953
R01 · FY2006 · AG · contact PI